Severe pneumonia in Young smokers in the province of Buenos Aires
DOI:
https://doi.org/10.56294/ri202611Keywords:
Pneumonia, tobacco use, inmunocompetent patients, young adult, severityAbstract
Introduction: Smoking is related to morphological alterations of the bronchial mucosa epithelium. In Argentina, 33.4% of the population between 18 and 64 years of age are smokers, with a predominance in the lower income areas of the country. According to the World Health Organization (WHO), 1.6 million people die of pneumonia every year, with smoking being a major risk factor for its development. Materials and methods: A prospective observational descriptive study was carried out at the Eurnekian Hospital in Ezeiza to describe the evolution of young adult patients with severe pneumonia. Data was collected through anamnesis and review of physical medical records of patients admitted with a diagnosis
of pneumonia.
Results: Thirty-eight young immunocompetent patients hospitalized with pneumonia were analyzed. The average age was 40 years, with a predominance of males (70.7%). The average number of years of consumption was 20, and 20 patients (55.2%) of the total were minors at the beginning of their smoking habit. With regard to the presence of previous pathologies, 7 patients (18.2%) were diabetic, 9 were hypertensive, 3 had suffered an acute myocardial infarction, 4 had suffered a cerebrovascular accident; 3 had advanced heart failure, 1 had renal failure and 3 had suffered tuberculosis for which they had received full treatment.
With regard to oxygen saturation on admission to hospital, 8 patients had saturation levels of between 80-84.9%, 21 between 85-90% and 9 >90%. The average length of stay in hospital was 5.8 days, with only 9 patients being hospitalized for between 10-14 days.
Conclusion: The results show that the onset of smoking habit is prior to the age of majority. We believe it is advisable to carry out more campaigns for the prevention of addictions and smoking cessation in adolescents and young adults, with an emphasis on primary health prevention.
References
1. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL. Harrison: Principios de Medicina Interna. 21ª ed. Vol. 1. Nueva York: McGraw-Hill Education; p. 1-7.
2. Garcia Bellmunt L, Sibila O. Mecanismos de defensa pulmonar. Arch Bronconeumol. 2010;46(Supl 1):3-7.
3. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res. 2008;57(11):497-503.
4. Chung KF, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219-42.
5. Organización Mundial de la Salud. Tabaco [Internet]. 2023 [citado 2025 abr 4]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/tobacco
6. Ministerio de Salud de la Nación. 1ra Encuesta Nacional de Factores de Riesgo 2005: Tabaco [Internet]. Buenos Aires: Ministerio de Salud; 2005 [citado 2025 abr 4]. Disponible en: https://bancos.salud.gob.ar/sites/default/files/2020-02/1ra_encuesta-nacional-factores-riesgo_2005_tabaco.pdf
7. Fundación Interamericana del Corazón Argentina. Encuesta Nacional sobre tabaco y nicotina en adolescentes 2024 [Internet]. Buenos Aires: FIC Argentina; 2024 [citado 2025 abr 4]. Disponible en: https://www.ficargentina.org/wp-content/uploads/2024/04/2404_encuesta-tabaco.pdf
8. Almirall J, Gonzales CA, Balanzo X, Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest. 1999;116(2):375-9.
9. Ramman AS, Swinburne AJ, Fedullo AQJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest. 1983;83(1):23-7.
10. Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, Welte T, et al. Suppression of pulmonary innate host defence in smokers. Thorax. 2009;64(2):144-9.
11. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135-45.
12. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
Published
Issue
Section
License
Copyright (c) 2026 Joaquín Roberto Malerba , Lorena Djament (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.